aTyr Pharma | LIFE - Pre Tax Profit


aTyr Pharma reported $-25.75M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Ardelyx USD -400K 467K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Cipla INR 11.69B 6.85B Dec/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Galapagos EUR -221.49M 117.07M Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Grifols EUR 257.85M 190.87M Dec/2024
Novartis USD 4.64B 445M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
United Therapeutics USD 444M 6M Dec/2025
Xoma USD 15.98M 24.58M Jun/2024